Bill modeled after similar legislation to help women make informed decisions
(Columbus) -State Senator Nina Turner (D-Cleveland) announced legislation today that would protect men in Ohio from the risks of PDE-5 inhibitors, drugs commonly used to treat symptoms of impotence. Turner's legislation would include provisions to document that the symptoms are not psychological in nature, and would guide men to make the right decision for their bodies. Physicians would be required to obtain a second opinion from a psychological professional to verify that a patient has a true medical malady before the medication could be prescribed.
"The men in our lives, including members of the General Assembly, generously devote time to fundamental female reproductive issues--the least we can do is return the favor," Senator Turner said. "It is crucial that we take the appropriate steps to shelter vulnerable men from the potential side effects of these drugs."
The legislation follows the FDA's recommendation that the evaluation of erectile dysfunction should include a determination of potential underlying causes and the identification of appropriate treatment following a complete medical assessment. Similar bills to more closely regulate reproductive health issues have been introduced in the state legislatures of Virginia, Oklahoma, Idaho, and most recently Pennsylvania.
"When a man makes a crucial decision about his health and his body, he should be fully aware of the alternative options and the lifetime repercussions of that decision," Senator Turner said today. Men will be more easily guided through the process of obtaining treatment for impotence so they can better understand and more effectively address their condition.
PDE-5 inhibitors can carry serious side effects such as priapism, hearing loss, and vision loss, and can be detrimental to men with heart problems, including heart pain, abnormal heart rhythms, high or low blood pressure, or a history of stroke.
"By implementing more intensive screenings before prescribing the medication and requiring outpatient educational services, we can do more to prevent the potential side effects linked to PDE-5 inhibitors," Senator Turner explained. "We must advocate for the traditional family, protect the sanctity of procreation, and ensure that all men using PDE-5 inhibitors are healthy, stable, and educated about their options--including celibacy as a viable life choice. This legislation will do just that."